Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04197765 · ClinicalTrials.gov registry record · NA
acTBS Treatment for Inpatient Subjects With Suicidality
A NA study of Suicidality, sponsored by University of California, Los Angeles.
- Active
- Registry status
- NA
- Development phase
- 40
- Enrollment target
- 1
- Study location
NCT04197765: Active NA study of Suicidality, sponsored by University of California, Los Angeles.
NCT04197765 is a NA study of Suicidality that is active but no longer recruiting, run by University of California, Los Angeles. The registered enrollment target is 40 participants, below the 395-participant average among 4 other Suicidality trials with a reported enrollment target (90% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04197765, a NA study of Suicidality, is active but no longer recruiting, sponsored by University of California, Los Angeles.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a pilot study to analyze the benefit of accelerated continuous Transcranial magnetic stimulation for inpatient subjects suffering with suicidal ideation. This study will enroll 40 inpatient subjects recruited from the Resnick Neuropsychiatric hospital. Subjects will be blinded and randomized to active or sham TMS treatment and will receive up to 5 assigned treatments per day. Subjects will also be asked to complete mood surveys throughout their participation. Participation in this study will last 7-10 days depending on scheduling.
Primary Outcome
This 5-item questionnaire is a self-report measure that asks completers to rate the frequency, controllability, closeness to attempt, distress, and interference of suicidal thinking with daily activities from 0-10, with 10 indicating extreme intensity. The SIDAS takes approximately 30-60 seconds to complete and has excellent internal reliability, sensitivity, and specificity. The score is calculated as the sum of the five items. Scores of 21 or above denote high suicidal ideation. A lower score
Conditions Studied
Interventions
- DEVICE Sham Comparator
- DEVICE accelerated Thetaburst stimulation
Study Locations (1)
California
- Resnick Neuropsychiatric Hospital - Los Angeles
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2020-01-01 |
| Est. Completion | 2029-01-01 |
| Phase | NA |
What the registry record for NCT04197765 still lists
NCT04197765 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 395-participant average among 4 other Suicidality trials with a reported enrollment target (90% lower).
The record links to 1 condition, with Suicidality appearing as the primary indexed condition, and to 2 interventions - of which Sham Comparator is the first listed.
NCT04197765 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT04197765 about?
NCT04197765 is a clinical study titled "acTBS Treatment for Inpatient Subjects With Suicidality". This is a pilot study to analyze the benefit of accelerated continuous Transcranial magnetic stimulation for inpatient subjects suffering with suicidal ideation. This study will enroll 40 inpatient subjects recruited from the Resnick Neuropsychiatric hospital. Subjects will be blinded and randomized...
What is the current status of trial NCT04197765?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2020-01-01. Estimated completion is 2029-01-01.
What conditions does trial NCT04197765 study?
This clinical trial studies the following conditions: Suicidality.
What interventions are being tested in trial NCT04197765?
The interventions under investigation include: Sham Comparator (DEVICE), accelerated Thetaburst stimulation (DEVICE).
Who is sponsoring clinical trial NCT04197765?
This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04197765 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Suicidality
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Assessing Improvements in Mood and Sleep Trial
RECRUITING · NA
-
Intensive Outpatient Treatment for Suicidal Veterans
COMPLETED · NA
-
Acceptability & Safety of Two Sequential Doses of Psilocybin in Bipolar Disorder II Depression and Suicidality
RECRUITING · Phase 2
-
Effectiveness of the Adapt for Life, Mental Wellness and Suicide Prevention Program
ACTIVE NOT RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI